Human Hepcidin for Patients Prescribed Therapeutic Phlebotomy
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

Human Hepcidin for Patients Prescribed Therapeutic Phlebotomy

Sponsor: La Jolla Pharmaceutical Company

A phase 2 study of LJPC-401 (synthetic human hepcidin) in combination with phlebotomy for treatment of iron overload in patients diagnosed with hereditary hemochromatosis.